CDC42 and breast carcinoma: Based on genomic and transcriptomic analysis by the Molecular Taxonomy of the Breast Cancer International Consortium (METABRIC) group, Luminal A tumours are enriched for aberrant expression of genes in the cell division control 42 homolog (CDC42) pathway [2] and linked by low levels of copy number aberration.